Cambridge, MA, United States of America

Andrea Carfi

This inventor holds 10 USPTO granted patents and 28 published patent applications, plus 3 CIPO patents and 7 EPO patents. Top assignees: Glaxosmithkline Biologicals Sa, Modernatx, Inc.. Active years: 2017-2026.

USPTO Granted Patents = 10 

% Patents Active = 90.0

 

 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Andrea Carfi**

Introduction

Andrea Carfi is an accomplished inventor based in Cambridge, MA, with an impressive portfolio of eight patents. His innovative work primarily focuses on advancements in the field of virology and immunology, particularly targeting respiratory pathogens and human cytomegalovirus.

Latest Patents

Among Carfi's notable inventions are the pre-fusion RSV F antigens. This invention pertains to the pre-fusion RSV F protein and polypeptides characterized by one or more amino acid mutations that stabilize the pre-fusion conformation or destabilize the post-fusion conformation. It also outlines methods for inducing an immune response to the pre-fusion RSV F, demonstrating his commitment to enhancing vaccine efficacy.

Another significant patent involves modified cytomegalovirus proteins and stabilized complexes. This patent describes mutant human cytomegalovirus pentamer complex polypeptides, methods of their creation, and their applications in HCMV protein complexes and compositions. In particular, the use of these modified HCMV polypeptides aims to stabilize HCMV complexes or unmask a pentamer epitope, showcasing Carfi's innovative approaches to viral challenges.

Career Highlights

Throughout his career, Andrea Carfi has contributed to leading biotechnology organizations, including GlaxoSmithKline Biologicals SA and ModernaTX, Inc. His expertise and understanding of virology have propelled his career and fostered significant advancements in vaccine development.

Collaborations

Collaboration is key to innovation, and Carfi has worked alongside esteemed colleagues such as Yingxia Wen and Claudio Ciferri. Their collective efforts have further enriched the research landscape and fostered breakthroughs in their respective fields.

Conclusion

Andrea Carfi's contributions to science and technology underscore the critical need for ongoing research and innovation in combating viral diseases. His patents reflect a dedication to improving public health through groundbreaking inventions, solidifying his status as a key player in the biotechnology industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…